124 related articles for article (PubMed ID: 8314305)
1. Increased expression of the matrix metalloproteinase 2 in differentiating Tera 2 human embryonal carcinoma cells.
Tienari J; Pertovaara L; Saksela O; Lehtonen E; Vartio T
Int J Cancer; 1994 Jan; 56(2):219-23. PubMed ID: 8314305
[TBL] [Abstract][Full Text] [Related]
2. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
Mackay AR; Ballin M; Pelina MD; Farina AR; Nason AM; Hartzler JL; Thorgeirsson UP
Invasion Metastasis; 1992; 12(3-4):168-84. PubMed ID: 1284126
[TBL] [Abstract][Full Text] [Related]
3. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
[TBL] [Abstract][Full Text] [Related]
4. Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells.
Abe T; Mori T; Kohno K; Seiki M; Hayakawa T; Welgus HG; Hori S; Kuwano M
Clin Exp Metastasis; 1994 Jul; 12(4):296-304. PubMed ID: 8039304
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 beta induces differential gene expression in aortic smooth muscle cells.
Keen RR; Nolan KD; Cipollone M; Scott E; Shively VP; Yao JS; Pearce WH
J Vasc Surg; 1994 Nov; 20(5):774-84; discussion 784-6. PubMed ID: 7966813
[TBL] [Abstract][Full Text] [Related]
6. Regulation of collagen degradation in the rat myocardium after infarction.
Cleutjens JP; Kandala JC; Guarda E; Guntaka RV; Weber KT
J Mol Cell Cardiol; 1995 Jun; 27(6):1281-92. PubMed ID: 8531210
[TBL] [Abstract][Full Text] [Related]
7. The expression and localization of urokinase-type plasminogen activator and its type 1 inhibitor are regulated by retinoic acid and fibroblast growth factor in human teratocarcinoma cells.
Tienari J; Alanko T; Lehtonen E; Saksela O
Cell Regul; 1991 Apr; 2(4):285-97. PubMed ID: 1905574
[TBL] [Abstract][Full Text] [Related]
8. Expression of type IV collagen and its degrading enzymes in squamous cell carcinoma of lung.
Nakagawa H; Yagihashi S
Jpn J Cancer Res; 1994 Sep; 85(9):934-8. PubMed ID: 7961122
[TBL] [Abstract][Full Text] [Related]
9. Expression of tissue inhibitor of metalloproteinase-1 and type IV collagenase/gelatinase messenger RNAs in human breast cancer.
Lindsay CK; Thorgeirsson UP; Tsuda H; Hirohashi S
Hum Pathol; 1997 Mar; 28(3):359-66. PubMed ID: 9042802
[TBL] [Abstract][Full Text] [Related]
10. Expression of metalloproteinases and tissue inhibitors of metalloproteinases in human osteoblast-like cells: differentiation is associated with repression of metalloproteinase biosynthesis.
Rifas L; Fausto A; Scott MJ; Avioli LV; Welgus HG
Endocrinology; 1994 Jan; 134(1):213-21. PubMed ID: 8275936
[TBL] [Abstract][Full Text] [Related]
11. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
Terada T; Okada Y; Nakanuma Y
Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
[TBL] [Abstract][Full Text] [Related]
12. Mosaic structure of the secreted ECM metalloproteases and interaction of the type IV collagenases with inhibitors.
Goldberg GI; Collier IE; Eisen AZ; Grant GA; Marmer BL; Wilhelm SM
Matrix Suppl; 1992; 1():25-30. PubMed ID: 1336109
[TBL] [Abstract][Full Text] [Related]
13. Localization of messenger RNA for tissue inhibitor of metalloproteinases-1 and type IV collagenases/gelatinases in monkey hepatocellular carcinomas.
Lindsay CK; Thorgeirsson UP
Clin Exp Metastasis; 1995 Sep; 13(5):381-8. PubMed ID: 7641422
[TBL] [Abstract][Full Text] [Related]
14. Expression and activity of MMPS and their regulators in ovarian cancer.
Naylor MS; Stamp GW; Davies BD; Balkwill FR
Int J Cancer; 1994 Jul; 58(1):50-6. PubMed ID: 8014015
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
16. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines.
Hofmann A; Laue S; Rost AK; Scherbaum WA; Aust G
Thyroid; 1998 Mar; 8(3):203-14. PubMed ID: 9545106
[TBL] [Abstract][Full Text] [Related]
17. Modulation of neutral protease expression in human mesangial cells by hyperglycaemic culture.
Abdel Wahab N; Mason RM
Biochem J; 1996 Dec; 320 ( Pt 3)(Pt 3):777-83. PubMed ID: 9003362
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines.
Afzal S; Lalani el-N ; Foulkes WD; Boyce B; Tickle S; Cardillo MR; Baker T; Pignatelli M; Stamp GW
Lab Invest; 1996 Feb; 74(2):406-21. PubMed ID: 8780160
[TBL] [Abstract][Full Text] [Related]
19. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer.
Gress TM; Müller-Pillasch F; Lerch MM; Friess H; Büchler M; Adler G
Int J Cancer; 1995 Aug; 62(4):407-13. PubMed ID: 7635566
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor-mediated stimulation of differentiating teratocarcinoma cells: evidence for paracrine growth regulation.
Tienari J; Alanko T; Saksela O; Vesterinen M; Lehtonen E
Differentiation; 1995 Oct; 59(3):193-9. PubMed ID: 7589903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]